Radioreceptor binding profile of the atypical antipsychotic olanzapine

被引:928
作者
Bymaster, FP
Calligaro, DO
Falcone, JF
Marsh, RD
Moore, NA
Tye, NC
Seeman, P
Wong, DT
机构
[1] ELI LILLY & CO,LILLY RES CTR,WINDLESHAM,SURREY,ENGLAND
[2] UNIV TORONTO,DEPT PHARMACOL,TORONTO,ON,CANADA
[3] UNIV TORONTO,DEPT PSYCHIAT,TORONTO,ON,CANADA
关键词
olanzapine; clozapine; haloperidol; antipsychotic; binding profile; dopamine; risperidone; seroquel; Org; 5222;
D O I
10.1016/0893-133X(94)00129-N
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The affinities of olanzapine, clozapine, haloperidol, and four potential antipsychotics were compared on binding to the neuronal receptors of a number of neurotransmitters. In both rat tissues and cell fines transfected with human receptors olanzapine had high affinity for dopamine D-1, D-2, D-4, serotonin (5HT)(2A), 5HT(2C), 5HT(3), alpha(1)-adrenergic, histamine H-1, and five muscarinic receptor subtypes. Olanzapine had lower affinity for alpha(2)-adrenergic receptors and relatively low affinity for 5HT(1) subtypes, GABA(A), beta-adrenergic receptors, and benzodiazepine binding sites. The receptor binding affinities for olanzapine teas quite similar in tissues from rat and human brain. The binding profile of olanzapine was comparable to the atypical antipsychotic clozapine, while the binding profiles for haloperidol, resperidone, remoxipride, Org 5222, and seroquel were substantially different from that of clozapine. The receptor binding profile of olanzapine is consistent with the antidopaminergic, antiserotonergic, and antimuscarinic activity observed in animal models and predicts atypical antipsychotic activity in man.
引用
收藏
页码:87 / 96
页数:10
相关论文
共 62 条
[1]  
ALTAR CA, 1986, BRAIN RES BULL, V16, P517
[2]   SOME ATYPICAL NEUROLEPTICS INHIBIT [H-3] SCH 23390 BINDING INVIVO [J].
ANDERSEN, PH ;
NIELSEN, EB ;
GRONVALD, FC ;
BRAESTRUP, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 120 (01) :143-144
[3]  
ARNT J, 1982, ACTA PHARMACOL TOX, V51, P321
[4]   Olanzapine versus placebo and haloperidol - Acute phase results of the North American double-blind olanzapine trial [J].
Beasley, CM ;
Tollefson, G ;
Tran, P ;
Satterlee, W ;
Sanger, T ;
Hamilton, S ;
Fabre, L ;
Small, J ;
Ereshefsky, L ;
True, J ;
Nemeroff, C ;
Risch, SC ;
Perry, PJ ;
Potkin, SG ;
Borison, RL ;
James, S ;
Meltzer, HY ;
Iqbal, N ;
Fann, WE ;
Gewirtz, GR ;
Landbloom, R ;
RoyByrne, PP ;
Tuason, VB ;
Carman, JS ;
Stokes, PE ;
Williams, R ;
Ancill, RJ ;
MacEwan, GW ;
Gujavarty, KS ;
Jones, B ;
Lohr, JB .
NEUROPSYCHOPHARMACOLOGY, 1996, 14 (02) :111-123
[5]  
BOLDEN C, 1992, J PHARMACOL EXP THER, V260, P576
[6]  
BOYAJIAN CL, 1987, J PHARMACOL EXP THER, V241, P1092
[7]   SPECIFIC BENZODIAZEPINE RECEPTORS IN RAT-BRAIN CHARACTERIZED BY HIGH-AFFINITY [DIAZEPAM-H-3] BINDING - (AFFINITY BINDING DIAZEPAM ANXIOLYTIC ACTIVITY BRAIN MEMBRANES REGIONAL DISTRIBUTION) [J].
BRAESTRUP, C ;
SQUIRES, RF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (09) :3805-3809
[8]  
BYLAND DB, 1976, MOL PHARMACOL, V12, P568
[9]   BINDING OF TYPICAL AND ATYPICAL ANTIPSYCHOTICS TO 5-HT1C AND 5-HT2 SITES - CLOZAPINE POTENTLY INTERACTS WITH 5-HT1C SITES [J].
CANTON, H ;
VERRIELE, L ;
COLPAERT, FC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 191 (01) :93-96
[10]   CLOZAPINE - NEUROLEPTIC-INDUCED EPS AND TARDIVE-DYSKINESIA [J].
CASEY, DE .
PSYCHOPHARMACOLOGY, 1989, 99 :S47-S53